Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.13NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.69NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.69NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.69NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.4.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.4.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.17NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.17NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CC.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CC.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CC.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BZ.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BZ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BZ.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CK.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CK.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CK.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.13NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.13NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CM.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CM.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.34NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1.34NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.34NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.35NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.35NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.35NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.1.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.1.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XAY.2.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XAY.2.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAY.2.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CH.1.1.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CH.1.1.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used